<DOC>
	<DOC>NCT00646594</DOC>
	<brief_summary>The purpose of this study is to determine whether Symbicort compared with Advair, will be more effective in controlling asthma in adults and adolescents.</brief_summary>
	<brief_title>Atlantis Symbicort</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Diagnosis of asthma Baseline lung function tests as determined by protocol Required and received treatment with inhaled corticosteroids within timeframe and doses specified in protocol Has required treatment with any noninhaled corticosteroid within previous 30 days, sensitivity to drugs specified in the protocol, or requires treatment with a betablockers Had cancer within previous 5 years or currently has any other significant disease or disorder as judged by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>inhaled cortocisteroids</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>Advair</keyword>
	<keyword>fluticasone/salmeterol</keyword>
</DOC>